access+affordability

Eleven U.S. state-treasurers are asking drugmaker Gilead Sciences to lower the price of its experimental remdesivir treatment for Covid-19, arguing the company is attempting to market an “old drug at prices that are disconnected from economic reality.”

The National MS Society supports appropriate step therapy protections to ensure that people with MS can get access to the medications they need, without detrimental delays.

As drug prices escalate, politicians in Washington and states have sought to address the problem in limited ways, focusing mostly on insulin, which more than 7 million Americans rely on to manage diabetes and whose price more than doubled from 2012-17.

Some 156 nations have joined a global scheme for fair distribution of future vaccines against COVID-19, an alliance led by the World Health Organization (WHO).

After announcing the first government clearance for a coronavirus vaccine, Russia delayed distributing it. It remains unclear how many people have received it.

Infections are a serious concern for people with CF, a fatal genetic disease that affects the lungs and digestive system.

Total payments for the HIV prevention pill exceeded $2 billion in 2018.

As the backbone of the nation’s primary-care safety net, the 340B program is the only thing standing between our patients and unaffordable insulin and other lifesaving prescription drugs.

NICE has announced its recommendation of Bristol-Myers Squibb’s blockbuster immunotherapy drug Opdivo (nivolumab) for the treatment of two non-small cell lung cancer (NSCLC) indications in the second-line.

Value-Based Care Opportunities in Medicaid

If you’re among the 1 in 3 people with Medicare who has diabetes, there’s some good news: starting in 2021, many participating drug plans will offer a 30-day supply of insulin for $35 or less per month through the Medicare Part D Senior Savings Model.

As government and private money pour into the global race for a Covid-19 vaccine, drugmakers are under great pressure to keep the shot affordable while also keeping investors happy.

With a supportive wife, five daughters and eight grandchildren, Tony Sullivan has something to fight for.

How a Monopoly on Remdesivir Led to Rationing

Trust in pharmaceutical companies vs. the FDA to look out for the best interests of Americans.